| P50 | author | Nimalan Arinaminpathy | Q60727538 |
| P2093 | author name string | W S Barclay | |
| | S Riley | |
| | B Grenfell | |
| | C Saad-Roy | |
| P2860 | cites work | Antibody recognition of a highly conserved influenza virus epitope | Q24655932 |
| | Influenza virus hemagglutinin stalk-based antibodies and vaccines | Q27001190 |
| | Structure of a Classical Broadly Neutralizing Stem Antibody in Complex with a Pandemic H2 Influenza Virus Hemagglutinin | Q27677191 |
| | A stable trimeric influenza hemagglutinin stem as a broadly protective immunogen | Q27701889 |
| | Pandemic influenza and the global vaccine supply. | Q30332964 |
| | Mucosal immunization with a candidate universal influenza vaccine reduces virus transmission in a mouse model. | Q30360144 |
| | Influenza vaccine: the challenge of antigenic drift. | Q30363606 |
| | Design and Characterization of a Computationally Optimized Broadly Reactive Hemagglutinin Vaccine for H1N1 Influenza Viruses. | Q30384878 |
| | Potent protection against H5N1 and H7N9 influenza via childhood hemagglutinin imprinting | Q30395224 |
| | Cross-protective immunity to influenza A viruses | Q30396399 |
| | Universal or Specific? A Modeling-Based Comparison of Broad-Spectrum Influenza Vaccines against Conventional, Strain-Matched Vaccines | Q30396482 |
| | Estimating Direct and Indirect Protective Effect of Influenza Vaccination in the United States | Q30400623 |
| | Annual vaccination against influenza virus hampers development of virus-specific CD8⁺ T cell immunity in children | Q30406576 |
| | Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis | Q30408691 |
| | Impact of cross-protective vaccines on epidemiological and evolutionary dynamics of influenza | Q30412892 |
| | Functional constraints of influenza A virus epitopes limit escape from cytotoxic T lymphocytes | Q33930372 |
| | "Herd immunity": a rough guide | Q34172602 |
| | Influenza vaccine--outmaneuvering antigenic shift and drift | Q34289987 |
| | Evidence for antigenic seniority in influenza A (H3N2) antibody responses in southern China | Q34350881 |
| | Protective Efficacy of the Conserved NP, PB1, and M1 Proteins as Immunogens in DNA- and Vaccinia Virus-Based Universal Influenza A Virus Vaccines in Mice. | Q35656657 |
| | Hemagglutinin stalk-based universal vaccine constructs protect against group 2 influenza A viruses. | Q37252968 |
| | T-cell-inducing vaccines - what's the future | Q37951575 |
| | Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies | Q38803189 |
| | A Perspective on the Structural and Functional Constraints for Immune Evasion: Insights from Influenza Virus | Q39397313 |
| | From Original Antigenic Sin to the Universal Influenza Virus Vaccine | Q40059787 |
| | A Universal Influenza Vaccine: The Strategic Plan for the National Institute of Allergy and Infectious Diseases. | Q54262077 |
| | How single mutations affect viral escape from broad and narrow antibodies to H1 influenza hemagglutinin. | Q55318229 |
| | A naturally protective epitope of limited variability as an influenza vaccine target | Q58382349 |
| P433 | issue | 164 | |
| P921 | main subject | pandemic | Q12184 |
| P304 | page(s) | 20190879 | |
| P577 | publication date | 2020-03-04 | |
| P1433 | published in | Journal of the Royal Society Interface | Q2492390 |
| P1476 | title | Population implications of the deployment of novel universal vaccines against epidemic and pandemic influenza | |
| P478 | volume | 17 | |